Mirador Therapeutics Appoints Gregg Gilbert As Chief Financial Officer

Sep 17, 2024•10 months ago

Position

Chief Financial Officer

Company

Mirador Therapeutics

Gregg Gilbert

San DiegoTherapeuticsBiotechnologyHealth Care

Description

Mirador Therapeutics, Inc has appointed Gregg Gilbert as chief financial officer. Mr. Gilbert brings more than 25 years of leadership experience in biopharma equity research analysis and investment banking to the role.

Company Information

Company

Mirador Therapeutics

Location

San Diego, California, United States

About

Mirador is a next-generation precision medicine company focused on immunology and inflammation. The company’s Mirador360 TM precision development engine leverages the latest advances in human genetics and cutting-edge data science to rapidly advance new precision medicines for patients living with chronic immune-mediated inflammatory and fibrotic diseases. Launched in 2024, Mirador has raised over $400 million from leading life sciences investors and is based in San Diego, CA.

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months

Related People

Mirador Therapeutics Appoints Gregg Gilbert As Chief Financial Officer

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Executive Insights

Related People

Gregg hidden

Olivier hidden

Allison hidden

Company Information